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Abstract
Background: We sought to analyse the impacts found, and the methods used, in a series of assessments of
programmes and portfolios of health research consisting of multiple projects.
Methods: We analysed a sample of 36 impact studies of multi-project research programmes, selected from a wider
sample of impact studies included in two narrative systematic reviews published in 2007 and 2016. We included impact
studies in which the individual projects in a programme had been assessed for wider impact, especially on policy or
practice, and where findings had been described in such a way that allowed them to be collated and compared.
Results: Included programmes were highly diverse in terms of location (11 different countries plus two multi-country
ones), number of component projects (8 to 178), nature of the programme, research field, mode of funding, time
between completion and impact assessment, methods used to assess impact, and level of impact identified.
Thirty-one studies reported on policy impact, 17 on clinician behaviour or informing clinical practice, three on a
combined category such as policy and clinician impact, and 12 on wider elements of impact (health gain, patient benefit,
improved care or other benefits to the healthcare system). In those multi-programme projects that assessed the
respective categories, the percentage of projects that reported some impact was policy 35% (range 5–100%), practice
32% (10–69%), combined category 64% (60–67%), and health gain/health services 27% (6–48%).
Variations in levels of impact achieved partly reflected differences in the types of programme, levels of collaboration
with users, and methods and timing of impact assessment. Most commonly, principal investigators were surveyed;
some studies involved desk research and some interviews with investigators and/or stakeholders. Most studies used a
conceptual framework such as the Payback Framework. One study attempted to assess the monetary value of a
research programme’s health gain.
Conclusion: The widespread impact reported for some multi-project programmes, including needs-led and
collaborative ones, could potentially be used to promote further research funding. Moves towards greater
standardisation of assessment methods could address existing inconsistencies and better inform strategic decisions
about research investment; however, unresolved issues about such moves remain.
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Background
The World Health Report 2013 argued that “adding to the
impetus to do more research is a growing body of evidence
on the returns on investment” [1]. While much of the evi-
dence on the benefits of research came originally from
high-income countries, interest in producing such evidence
is spreading globally, with examples from Bangladesh [2],
Brazil [3], Ghana [4] and Iran [5] published in 2015–2016.
Studies typically identify the impacts of health research in
one or more of categories such as health policy, clinical
practice, health outcomes and the healthcare system. Indi-
vidual research impact assessment studies can provide
powerful evidence, but their nature and findings vary
greatly [6–9] and ways to combine findings systematically
across studies are being sought.
Previous reviews of studies assessing the impact of
health research have analysed the methods and frame-
works that are being developed and applied [6, 8–13].
An additional question, which has to date received less
attention, is what level of impact might be expected
from different types of programmes and portfolios of
health research.
This paper describes the methods used in two succes-
sive comprehensive reviews of research impact studies,
by Hanney et al. [6] and Raftery et al. [9], and justifies a
sample of those studies for inclusion in the current ana-
lysis. We also consider the methodological challenges of
seeking to draw comparisons across programmes that go
beyond summing the impacts of individual projects
within programmes. Importantly, programmes would
need to be comparable in certain ways for such cross-
programme comparisons to be legitimate.
For this paper, we deliberately sought studies that had
assessed the impact of all projects in multi-project pro-
grammes, whether coordinated or not. We focused on
such multi-project programmes because this approach
offered the best opportunities for meaningful compari-
sons across programmes both of the methods and
frameworks most frequently used for impact assessment
and, crucially, of the levels of impact achieved and some
of the factors associated with such impact. Furthermore,
such an approach focused attention on the desirability of
finding ways to introduce greater standardisation in re-
search impact assessment. However, we also discuss the
severe limitations on how far this analysis can be taken.
Finally, we consider the implications of our findings for
investment in health research and development and the
methodology of research on research impact.
Methods
The methods used to conduct the two previous reviews
on which this study is based [6, 9] are described in Box 1.
Box 1 Search strategy of two original reviews
For the current study the main inclusion criterion was
studies that had attempted to identify projects within
multi-project programmes in which investigators had
claimed to have made some wider impact, especially on
policy or practice, and/or for which there was an external
assessment showing such impact. We included only one
paper per impact assessment and therefore, for example,
excluded papers that reported in detail on a subset of the
projects included in a main paper. We did not include stud-
ies that reported only on the total number of incidents of
impacts on policy claimed for a whole programme, rather
than the number of projects claiming to make such impact.
We included only those studies where the findings were
described in a way that allowed them to be collated with
others, then analysed and presented in a broadly standar-
dised way. This meant, for example, that the categories of
impacts described by the study had to fit into at least one
of a number of broad categories.
We defined the categories as broadly as possible to be in-
clusive and avoid creating overlapping categories. Following
The two narrative systematic reviews of impact assessment studies on
which this paper is based were conducted in broadly similar ways that
included systematic searching of various databases and a range of
additional techniques. Both were funded by the United Kingdom
National Institute for Health Research (NIHR) Health Technology
Assessment (HTA) Programme.
The searches from the first review, published in 2007, were run from 1990
to July 2005 [6]. The second was a more recent meta-synthesis of studies
of research impact covering primary studies published between 2005 and
2014 [9]. The search strategy used in the first review was adapted to take
account of new indexing terms and a modified version by Banzi et al. [11]
(see Additional file 1: Literature search strategies for the two reviews, for a
full description of the search strategies). Although the updated search
strategy increased the sensitivity of the search, filters were used to improve
the precision and study quality of the results.
The electronic databases searched in both studies included: Ovid
MEDLINE, MEDLINE(R) In-Process, EMBASE, CINAHL, the Cochrane Library
including the Cochrane Methodology Register, Health Technology
Assessment Database, the NHS Economic Evaluation Database and Health
Management Information Consortium, which includes grey literature such
as unpublished papers and reports. The first review included additional
databases not included in the updated review: ECONLIT, Web of
Knowledge (incorporating Science Citation Index and Social Science
Citation Index), National Library of Medicine Gateway Databases and
Conference Proceedings Index.
In addition to the standard searching of electronic databases, other methods
to identify relevant literature were used in both studies. This included in
the second review an independent hand-searching of four journals
(Implementation Science, International Journal of Technology Assessment in
Health Care, Research Evaluation, Health Research Policy and Systems), a
list of known studies identified by team members, reviewing publication lists
identified in major reviews published since 2005, and citation tracking of
selected key publications using Google Scholar.
The 2007 review highlighted nine separate frameworks and approaches
to assessing health research impact and identified 41 studies describing
the application of these, or other, approaches. The second review
identified over 20 different impact models and frameworks (five of them
continuing or building on ones from the first review) and 110 additional
studies describing their empirical applications (as single or multiple case
studies), although only a handful of frameworks had proven robust and
flexible across a range of examples.
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an initial scan of the available studies we identified four
impact categories that were broadly compatible with, but
not necessarily identical to, the impact categories in the
widely-used Payback Framework [14, 15] and the Canadian
Academy of Health Sciences adaptation of that framework
[10]. The categories were impact on health policy or on a
healthcare organisation, informing practice or clinician
behaviour, a combined category covering policy and
clinician impact, and impact on health gain, patient benefit,
improved care or other benefits to the healthcare system.
Studies were included if they had presented findings in
one or more of these categories in a way that could
allow standardised comparison across programmes. In
some cases, the studies presented findings solely in
terms of the numbers of projects that had claimed or
been shown to have had impact in a particular category.
These had to be standardised and presented as percent-
ages. Each study was given the same weight in the ana-
lysis, irrespective of the number of individual projects
covered by the study. For each of the four categories of
impacts we then calculated the median figure for those
studies showing the percentage of projects that had
claimed to make an impact in that category. We also
presented the full range of percentages in each category.
We extracted data on methods and conceptual frame-
works for assessment of research impact described in each
study, and on categories of factors considered by the au-
thors to be relevant for the level of impact achieved. In
identifying the latter, our approach was informed by a
range of international research literature, in particular the
1983 analysis by Kogan and Henkel of the importance of
researchers and potential users working together in a col-
laborative approach, the role of research brokers, and the
presence of bodies that are ready to receive and use the
research findings [16, 17]. Other papers on these and re-
lated themes that influenced our approach to the analysis
included literature related to North and Central America
[18–21], Africa [22], the European Union [23], and the
United Kingdom [6, 14, 24], as well as international stud-
ies and reviews [25–31].
Results
Thirty-six studies met the inclusion criteria for this ana-
lysis [6, 32–66]. These were highly diverse in terms of
the location of the research, nature and size of the fun-
der’s research programme or portfolio, the fields of re-
search and modes of funding, time between completion
of the programme and impact assessment, the methods
(and sometimes conceptual frameworks) used to assess
the impact, and levels of impact achieved. A brief sum-
mary of each study is provided in Table 1.
The studies came from 11 different countries, plus a
European Union study and one covering various locations
in Africa. The number of projects supplying data to the
studies ranged from just eight in a study of an occupa-
tional therapy research programme in the United
Kingdom [59], to 22 operational research projects in
Guatemala [35], 153 projects in a range of programmes
within the portfolio of the Australian National Breast
Cancer Foundation [38], and 178 projects from the Hong
Kong Health and Health Services Research Fund [51].
In terms of the methods used to gather data about the
projects in a programme, 21 of the 36 studies surveyed
the researchers, usually just each project’s Principal or
Chief Investigator (PIs), either as the sole source of data
or combined with other methods such as documentary re-
view, interviews and case studies. Six studies relied exclu-
sively, or primarily, on documentary review and desk
analysis. In at least three studies, interviewing all PIs was
the main method or key starting point used to identify fur-
ther interviewees. The picture is complicated because some
studies used one approach, usually surveys, to gain informa-
tion about all projects, and then supplemented that with
other approaches for selected projects on which case stud-
ies were additionally conducted, and often involved inter-
views with PIs. In total, over a third of the studies involved
interviews with stakeholders, again sometimes in combin-
ation with documentary review. Many studies drew on a
range of methods, but two examples illustrate a particularly
wide range of methods. In the case of Brambila et al. [35] in
Guatemala, this included site visits which were used to sup-
port key informant interviews. Hera’s [46] assessment of the
impact of the Africa Health Systems Initiative Support to
African Research Partnerships involved a range of methods.
These included documentary review, and programme level
interviews. Project level information was obtained from
workshops for six projects and from a total of 12 interviews
for the remaining four projects. In addition, they used par-
ticipant observation of an end-of-programme workshop, at
which they also presented some preliminary findings. In
this instance, while the early timing of the assessment
meant that it was unable to capture all the impact, the pro-
gramme’s interactive approach led to some policy impact
during the time the projects were underway.
In 20 of the 36 studies, the various methods used were
organised according to a named conceptual framework
(see Hanney et al. [6] and Raftery et al. [9] for a sum-
mary of all these frameworks); 16 of the 36 studies drew
partly or wholly on the Payback Framework [15]. A
series of existing named frameworks each informed one
of the 36 studies, and included the Research Impact
Framework [24], applied by Caddell et al. [37]; the
Canadian Academy of Health Sciences framework [10],
applied by Adam et al. [32]; the Banzi Research Impact
model [11], applied by Milat et al. [53]; and the Becker
Medical Library model [67], applied by Sainty [59].
In addition, various studies were identified as draw-
ing, at least to some degree, on particular approaches,
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albeit without an explicitly named framework being de-
scribed. Jacob and Battista [47] developed and applied
their own approach to evaluate the impact of studies con-
ducted by the Quebec Council of Health Care Technology
Assessments (CETS); the approach was broadly replicated
in a further evaluation of the impact from CETS [48] and
informed subsequent studies in Quebec [52], France [34]
and Austria [66]. The interactive approach was referred to
by several studies [35, 46]. The study by Molas-Gallert et
al. [54] of the impact from a programme of AIDS research
funded by the United Kingdom’s Economic and Social Re-
search Council used an approach that they subsequently
further developed with Spaapen et al. [23] in the Social
Impact Assessment Methods through the study of Pro-
ductive Interactions (SIAMPI) approach.
Only one included study assessed the monetary value of a
research programme’s resultant health gain. Johnston et al.’s
[49] assessment of the impact from a National Institutes of
Health (NIH) programme of clinical trials in the United
States is described in some detail here because studies
providing a rate of return were seen in the World Health
Report as key evidence for promoting the future funding of
health research [1]. For the trials identified as making an
impact in terms of health gain and/or cost savings,
Johnston et al. [46] employed a bottom-up approach. They
identified cost-utility estimates for the interventions imple-
mented following the NIH research to obtain a per patient
net monetary benefit. A timeline of usage was constructed
for each of the interventions to produce a population time-
line of net monetary benefit and was related to the invest-
ment in research. The results indicated an impact, with a
return on investment for the whole programme of 46% per
year. However, the authors acknowledged the difficulty of
acquiring the necessary data to conduct an exercise of this
kind, with only 8 out of 28 trials contributing the benefits
used to calculate the rate of return on investment. While
we did not have a category related specifically to the eco-
nomic impacts of health research, we included this study in
the health gain category because the latter was a key step
towards being able to calculate monetary value and was
identified as occurring in six out of the 28 projects (21%).
Despite the diversity, each of the 36 studies reported on
the number of projects in the multi-project programme
making an impact in one, or more, of four broad categories.
The number of projects reporting on each category, and
the number (and range) of projects that reported having
achieved some such impact is set out in Table 2.
One example from the various studies can be used to
illustrate what is included in each of the four types of
impact. The 1997 study by Jacob and McGregor [48] re-
ported that 86% of the HTAs conducted in Canada by
the Quebec CETS had influenced policy. One of these
HTAs found that the likelihood of health benefits from
routine preoperative chest radiography was extremely
slender; prior to the publication of that HTA report, 55
out of 118 hospitals questioned had a policy of using
such routine chest radiography, yet 3 years later, all but
three had abandoned this policy and in 79% of cases the
HTA was cited as a reason for the policy change. In
terms of impact on practice, in 2007, Kwan et al. gave
the following as an example of the local impact on pro-
vider behaviour made by the health and health services
research programme in Hong Kong: “improved reporting
of unintentional child injury cases and liaison between
the Hospital Authority Informatics and Accident and
Emergency” ([51], p. 8).
Illustrating the combined category, Milat et al. [53] used
a category called ‘Policy and practice impacts’ in their 2013
assessment of the impact from the research funded in
Australia by the New South Wales Health Promotion Dem-
onstration Research Grants Scheme. While the analysis
provided overall figures only for this combined category,
the few examples that were given were presented separately
for policy impacts and practice impacts. In some, but not
all, instances the accounts covered both dimensions, for ex-
ample, research informed policy planning by identifying
areas for investment in tai chi for older people (as a way of
preventing falls) and smoking cessation brief interventions.
Then, in terms of practice, the research in those same two
areas helped inform professional development for the
relevant staff providing the services. An example of health
gain comes from one of the NIH trials analysed in the 2006
assessment by Johnston et al. [49] described above, where
the authors estimated that implementation of the findings
from the trial of the use of tissue plasminogen activator in
cases of acute ischemic stroke, published in 1995, had a
projected health gain in the 10 years after funding was
completed of 134,066 quality-adjusted life years.
For each category, apart from the combined one, there was
a wide range in the proportion of studies per programme that
had demonstrated (or claimed) impact in each category.
Table 2 Analysis of quantitative data from 36 studies reporting
on findings from each project in a multi-project programme
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Most included studies had considered key factors that
might help explain the level of impact achieved (see last
column in Table 1 for direct quotes, or comments that in
most cases came from the original paper). Differences in
impact appeared to relate partly to the approaches used
and the timing of the assessment. For example, one study
that appeared to shown a very low proportion of projects
with impact on policy had assessed this purely through
desk analysis of end-of-project reports. Such an approach
restricted the opportunities to identify the actual levels of
impact achieved, as opposed to the expected levels of im-
pact, which were much higher and at least some of which
would presumably have arisen later [39].
Various features of the different programmes of research
also influenced the levels of impact achieved. In four stud-
ies of research programmes, 10% or fewer of PIs reported
that their research had made an impact on policy, but
three of these studies [38, 50, 65] included basic research
(from which direct policy impact would be much less
likely to occur) and, in two of those, assessment of impact
was performed relatively soon after completion of the
research.
While the median for the 31 studies reporting on pol-
icy impact made by programmes was 35% of projects
making such an impact, the interquartile range was 20–
70%. This reflects the existence of both a group of stud-
ies, as described above, where a very low proportion of
projects informed policies, and a group of studies with a
very high proportion of projects informing policies. In
fact, a median of 77% (range 29–100%) of projects in the
nine included HTA programmes [6, 34, 43, 44, 47, 48,
52, 55, 66] had had a demonstrable impact on policy.
Even within this group of programmes, the type of re-
search conducted varied. Most were technology ap-
praisal reviews that had usually been requested by those
making decisions for the relevant health service about
funding (or disinvesting in) particular technologies or
services. In some cases, an extremely high proportion of
projects in these programmes made an impact on policy;
for example, 97% of the assessments from the Austrian
HTA programme were classified as making at least some
impact on coverage policies [66], as were 100% of the
HTA reports from the HTA unit of McGill University
Health Centre in Quebec, Canada [52]. By contrast,
while the Health Care Efficiency Research programme
from the Netherlands was classified as an HTA
programme, it included a large responsive mode element
and most studies were prospective clinical trials and im-
pact assessment occurred soon after the end of the trials
[55]; a lower proportion of projects in these studies
(29%) had demonstrated a policy impact.
The review of programmes funded in the first decade
of the United Kingdom HTA Programme showed that,
overall, 73% of projects had an impact on policy [6]. Of
these, 96% of technology appraisal reviews undertaken
to inform the work of the, then, National Institute for
Health and Clinical Excellence, actually did so (that is,
they were commissioned to inform the work of a specific
user body), and 60% of other projects (mostly trials) had
a direct impact on policy. The 60% figure for these latter
studies compares favourably with the median of 35% in
our sample overall, and is probably due to the fact that,
even though the projects were not usually commissioned
by a specific user body, they were on topics that had
been identified as meeting a need within the healthcare
system. In only four of the 22 non-HTA programmes
that reported making an impact on policy was the
claimed figure higher than 50% of projects [46, 56, 57,
60]. In three of those [46, 56, 57], the authors identified
involvement of potential users in agenda setting and/or
interaction over the research as a key factor facilitating
impact. For example, Reed et al. said that the figure of
53% of projects from a programme of primary care re-
search in Australia making an impact on policy and or-
ganisational decisions reflected “a high level of
engagement of the researchers with potential users of
their research findings” ([57], p. 5) (See Table 1 for fur-
ther details).
Similarly, of the seven non-HTA programmes with a
high proportion of projects making an impact in terms
of informing practice or clinician behaviour, three
highlighted the importance of interaction with potential
users [32, 33, 51] and a further two were small-scale
funding initiatives where the impact was often on clini-
cians at the location where the research had been con-
ducted [37, 59]. In all three of the programmes where
the impact was in the combined policy and practice cat-
egory the proportion of projects making an impact was
at least 60%, and there was interaction with users and/or
the research met their needs [35, 41, 53].
Finally, in some instances observations were recorded
on how the impact evaluations of whole programmes of
work had been, or could be, used to inform policies of
the research funding body whose work had been
assessed and/or used to highlight the benefits that arise
from donating to medical research charities. Examples
include public research funders, such as the Catalan
Agency for Health Information, Assessment and Quality,
and the Northern Ireland Executive [32, 58], and
medical research charities such as Asthma UK and the
Australian National Breast Cancer Foundation [38, 45].
Discussion
The findings provide lessons about how a range of
methods for assessing research impact can be applied,
with surveys of PIs being the most frequently used, but
interviews and desk analysis also being adopted as alter-
natives or supplements. Such methods could be adopted
Hanney et al. Health Research Policy and Systems  (2017) 15:26 Page 14 of 21
elsewhere in future research impact assessments. Fur-
thermore, the methods adopted and the whole impact
study were often, but not always, organised using an
existing conceptual framework. The various approaches
used in impact assessments have different strengths and
weaknesses, and a range of theoretical underpinnings. A
selection of six key established frameworks was analysed
in Greenhalgh et al. [8], namely the Payback Framework
[14], the Research Impact Framework [24], the Canadian
Academy of Health Sciences framework [10], monetary
value approaches [68], social impact assessment [23, 69]
and the Research Excellence Framework (REF) [70], a
pioneering approach used in the United Kingdom to as-
sess the impact from university research groups and on
which considerable subsequent analysis has been con-
ducted [71]. While the approach used in the REF is not
related to specific programmes of research, but to the
research of teams who often had multiple sources of
funding, the REF built on approaches originally devel-
oped to assess the impact of research programmes. The
first five of the six frameworks highlighted by Green-
halgh et al. [8] helped inform at least one of the 36 stud-
ies in this current analysis and, according to the Higher
Education Funding Council for England, the sixth (i.e.
the REF) was itself partly informed by studies applying
the Payback Framework [72]. These six key frameworks
are described in Box 2.
Box 2 Summary of major impact assessment frameworks
One of the featured approaches currently receiving
more attention is the attempt to put a monetary value
on the impact of health research, and in particular stud-
ies involving attempts to value the health gain from re-
search. Various examples of the latter were identified in
the two reviews [73–79]. One study, that of Johnston et
al. [49], occupies a particular place in the consideration
of frameworks because it included all individual projects
within a programme (see above) and, while all of the
projects were examined, only a small proportion were
identified as making a measurable impact. Those pro-
jects ensured the programme as a whole had a high rate
of return. Some other studies with a more limited scope
have also used a bottom-up approach to assess the im-
pact of specific projects, but have not gone as far as
attempting a comprehensive valuation of the impact of a
whole programme of research. Nevertheless, such stud-
ies can indicate probable minimum levels of returns
from the whole programme studied [79].
It is important to acknowledge that this review has a
number of limitations. First, fine distinctions had to be
made about which studies to include, and some studies that
initially seemed relevant had to be excluded because data
extracted could not be meaningfully combined with those
of other studies, thus reducing the comprehensiveness of
the review. The seven studies [80–86] assessing the impact
of multi-project programmes that were included in the two
reviews on which this study was based, but excluded from
this current analysis, are listed on Table 3, along with rea-
sons for their exclusion.
Second, each of the included studies was liable to have
inherent weaknesses associated with the type of data gath-
ering techniques employed in assessing impact from
multi-project programmes. Many of the studies relied on
self-reported survey data, and some of them acknowl-
edged potential concerns about such data [51]. Neverthe-
less, approaches such as triangulation can somewhat
mitigate these weaknesses and, in at least four examples,
data were collected both by surveys and interviews and, in
each case, the self-reported survey data did not seem, on
average, to over-emphasise the level of impact [6, 36, 42,
45]. A further limitation with surveys is that the response
rate was generally between 50% and 75%, with only four
studies receiving replies from more than three-quarters of
projects: Kwan et al. [51], 87%; Oorwijn et al. [55], 79%;
Soper and Hanney [61], 83%; and Wooding et al. [65],
87%. Other approaches, such as the desk analysis based
on end of project reports [39], obtained data from a higher
proportion of projects, but, as described above, provided
limited opportunities to gather data on actual impacts
achieved. To the extent that differences in the impact
identified for each programme reflect differences in the
approach used to conduct the assessment, there will be
limitations in drawing lessons from the overall dataset of
36 assessments of the impact from programmes.
Third, in various studies, it was observed that the im-
pact assessment was occurring at a time that was too
early for some, or most, of the research to have had time
to make an impact [38, 39, 42, 55, 65]. In such cases, the
reported level of impact achieved was not only likely to
be lower than it would have been in a later assessment,
but also it might look comparatively lower than that
from other programmes included in the analysis where
the assessment took place some years after the research
had been completed. This again complicates attempts to
draw lessons from the overall dataset of 36 programmes.
Fourth, in order to facilitate the analysis, it was necessary
to create a small number of impact categories, but the defi-
nitions for impact categories used in the diverse studies var-
ied widely. Therefore, compromises had to be made and
not all the examples included in each category had been de-
fined in precisely the same way; therefore, what was in-
cluded in a category from one study might not exactly
match what was included in the same category from an-
other study. Particular problems arose in relation to
whether there should be a ‘cost-savings’ category. There has
been considerable debate about the place for cost-savings
within an impact categorisation [9]; it was decided not to
include a separate cost-saving category in this current ana-
lysis. However, various studies had cost-savings as one
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element in the broader category of ‘impact on health gain,
patient benefit, improved care or other benefits to the
healthcare system’ and these were included.
The Payback Framework
Developed by Buxton and Hanney in 1996, the Payback Framework
consists of two elements, namely a logic model of the seven stages of
research from conceptualisation to impact and five categories to classify
the paybacks [14]:
• knowledge (e.g. academic publications)
• benefits to future research (e.g. training new researchers)
• benefits to policy (e.g. information base for clinical policies)
• benefits to health and the health system (including cost savings
and greater equity)
• broader economic benefits (e.g. commercial spin-outs)
Two interfaces for interaction between researchers and potential users
of research (‘project specification, selection and commissioning’ and
‘dissemination’) and various feedback loops connecting the stages are
seen as crucial. The Payback Framework can be applied through surveys,
which can be applied to all PIs but have various limitations or to case
studies. For the latter, researcher interviews are combined with
document analysis and verification of claimed impacts to prepare a
detailed case study containing both qualitative and quantitative
information; this provides a fuller picture than surveys, but is more
labour intensive.
Research Impact Framework (RIF)
Originally developed by Kuruvilla et al. [24] for academics who were
interested in measuring and monitoring the impact of their own
research, RIF is a ‘light touch’ checklist intended for use by individual
researchers who seek to identify and select impacts from their work.
Categories include
• research-related impacts
• policy and practice impacts
• service (including health) impacts
• ‘societal impact’ (with seven sub-categories)
Because of its (intentional) trade-off between comprehensiveness and
practicality, it generally produces a less thorough assessment than the
Payback Framework and was not designed to be used in formal impact
assessment studies by third parties. However, the approach proved to
be highly acceptable to those researchers with whom it was applied.
Canadian Academy of Health Sciences (CAHS) Framework
CAHS Framework was developed from the Payback Framework through a
multi-stakeholder consensus-building process; it is claimed to be a
‘systems approach’ that takes greater account of non-linear influences [10].
It encourages a careful assessment of context and the subsequent consid-
eration of impacts under five categories:
• advancing knowledge (measures of research quality, activity,
outreach and structure)
• capacity building (developing researchers and research
infrastructure)
• informing decision-making (decisions about health and healthcare,
including public health and social care, decisions about future
research investment, and decisions by public and citizens)
• health impacts (including health status, determinants of health –
including individual risk factors and environmental and social
determinants – and health system changes)
• economic and social benefits (including commercialisation, cultural
outcomes, socioeconomic implications and public understanding of
science)
For each category, a menu of metrics and measures (66 in total) is
offered, and users are encouraged to draw on these flexibly to suit their
circumstances. By choosing appropriate sets of indicators, CAHS can be
used to track impacts within any of the four ‘pillars’ of health research
(basic biomedical, applied clinical, health services and systems, and
population health – or within domains that cut across these pillars) and
at various levels (individual, institutional, regional, national or
international).
Monetisation models
Monetisation models, which are mostly at a relatively early stage of
development [68], express returns on research investment in various ways,
including as cost savings, the monetary value of net health gains via cost
per quality-adjusted life year using metrics such as willingness-to-pay or
opportunity cost, and internal rates of return (return on investment as an
(Continued)
annual percentage yield). These models draw largely from the economic
evaluation literature and differ principally in terms of which costs and
benefits (health and non-health) they include and in the valuation of
seemingly non-monetary components of the estimation. Prevailing
debates on monetisation models of research impact centre on the nature
of simplifying assumptions in different models and on the balance
between ‘top down’ approaches (which start at a macro level and consider
an aggregate health gain, usually at a national level over a specific period,
and then consider how far a (national) body of research might have been
responsible for it arising) or ‘bottom-up’ approaches (which start with
particular research advances, sometimes all the projects in a specific
programme, and calculate the health gain from them).
Societal impact assessment (SIA)
Used mainly in the social sciences, SIA emphasises impacts beyond
health. Its protagonists distinguish the social relevance of knowledge
from its monetised impacts, arguing that the intrinsic value of
knowledge may be less significant than the varied and changing social
configurations that enable its production, transformation and use.
Assessment of SIA usually begins by self-evaluation by a research team
of the relationships, interactions and interdependencies that link it to
other elements of the research ecosystem (e.g. nature and strength of
links with clinicians, policymakers and industry), as well as external peer
review of these links. SIA informed the Evaluating Research in Context
programme that produced the Sci-Quest model [69] and also the
EU-funded SIAMPI (Social Impact Assessment Methods through the
study of Productive Interactions) framework [23].
Sci-Quest was described by its authors as a ‘fourth-generation’ approach
to impact assessment – the previous three generations having been
characterised, respectively, by measurement (e.g. an unenhanced logic
model), description (e.g. the narrative accompanying a logic model) and
judgement (e.g. an assessment of whether the impact was socially
useful or not). Fourth-generation impact assessment, they suggest, is
fundamentally a social, political and value-oriented activity and involves
reflexivity on the part of researchers to identify and evaluate their own
research goals and key relationships [69]. Whilst the approach has many
theoretical strengths, it has been criticised for being labour intensive to
apply and difficult to systematically compare across projects and
programmes.
United Kingdom Research Excellence Framework (REF)
The 2014 REF – an extensive exercise developed by the Higher
Education Funding Council for England to assess United Kingdom
universities’ research performance – allocated 20% of the total score to
research impact [70]. Each institution submitted an impact template
describing its strategy and infrastructure for achieving impact, along
with several four-page impact case studies, each of which described a
programme of research, claimed impacts and supporting evidence.
These narratives, which were required to follow a linear and time-bound
structure (describing research undertaken between 1993 and 2013,
followed by a description of impact occurring between 2008 and 2013)
were peer-reviewed by an intersectoral assessment panel representing
academia and research users (industry and policymakers). Almost 7000
impact case studies were produced for the 2014 REF; these have been
collated in a searchable online database on which further research is
currently being undertaken [71]. Independent evaluation by RAND
concluded that the narrative form of the REF impact case studies and
their peer review by a mixed panel of experts from within and beyond
academia had been a robust and fair way of assessing research impact.
In its internal review of the REF, the members of Main Panel A, which
covered biomedical and health research, noted that “International MPA
[Main Panel A] members cautioned against attempts to ‘metricise’ the
evaluation of the many superb and well-told narrations describing the
evolution of basic discovery to health, economic and societal impact” [70].
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A final limitation is that each project counted equally
to the final tally, and the question of whether impact
had occurred was framed as a binary yes/no. This meant
that large, well-conducted projects that had produced
very significant impacts counted the same as smaller,
more methodologically questionable projects whose im-
pact was limited (but which could still be said to have
occurred). In quite a few of the individual impact assess-
ments this limitation was reduced because more detailed
case studies were also conducted on selected case stud-
ies. These were often reported to provide examples of
the significant impact. However, in our current analysis,
any supplementary case studies were not included in the
data used to construct Table 2, which is the main com-
parative account of the findings.
Given the various limitations, the findings should be
viewed with a degree of caution. Nevertheless, the in-
cluded studies do present evidence of wide-ranging
levels of impact resulting from diverse programmes of
health research. Quite large numbers of projects made at
least some impact, and case studies often illustrated ex-
tensive impact arising from certain projects. Our find-
ings resonate with theoretical models of research
impact, namely impact is more likely to be achieved
when the topics of applied research, and how it might
best be conducted, are discussed with potential users of
the findings and when mechanisms are in place to re-
ceive and use the findings [6, 13, 16–21, 28–30]. We also
found variations depending on the nature of the research
being conducted. These points can be illustrated by
some of the more notable examples from Table 1. For
example, in the case of 100% of HTA reports from the
HTA unit of McGill University Health Centre in Que-
bec, Canada, the impact was said to be because of “(i)
relevance (selection of topics by administration with on-
site production of HTAs allowing them to incorporate
local data and reflect local needs), (ii) timeliness, and
(iii) formulation of policy reflecting community values by
a local representative committee” ([52], p. 263). In the
case of 97% of the assessments from the Austrian HTA
programme being classified as making at least some im-
pact on coverage policies [66], there were features of the
Austrian policymaking structures that facilitated the use
of HTA reports. The authors explained that, to be used,
the HTA reports “need primarily to be in German lan-
guage and they have to be produced within a time period
that is strongly linked to the decision-making process”
([66], p. 77). By contrast, and as noted above, while the
Health Care Efficiency Research programme from the
Netherlands was also classified as an HTA programme,
it included a large responsive mode element and most
studies were prospective clinical trials rather than the
Table 3 Seven excluded studies
Author, date, location Programme/speciality Reason for exclusion
Alberta Heritage Fund for
Medical Research, 2003 [80];
Alberta, Canada
Alberta Heritage Fund for
Medical Research HTA
programme
The number of projects in which any impact (only on policy)
was identified was described as ‘most’, which could not be
included in the statistical analysis (NB: this is a different study
than the one with the same author and same year that was
included in the analysis as reference [33])
Aymerich et al., 2012 [81],
Spain
Network centre for research in
epidemiology and public
health
Data for impact on reviews and on guidelines/other policies
was combined making it impossible to identify the specific
policy impact that would have been made by the
contribution to guidelines, etc.; the healthcare benefits were
potential not actual
Catalan Agency for HTA and
Research, 2006 [82], Catalonia,
Spain
TV3 telethon for biomedical
research in Catalonia: different
speciality each year
Most of the data on impacts seemed to be potential impacts,
and the data that were available were presented as total
instances not the percentage of projects reporting the impact
category
Cohen et al., 2015 [83],
Australia
National Health and Medical
Research Council: intervention
studies in various programmes
While it was a multi-project assessment covering 70 eligible
intervention projects, they came from more than one
programme and were not the total number of projects from
the programmes of which they were part
NHS Executive Trent, 1997 [84],
United Kingdom
Programme of the Trent
Region of the NHS: wide range
of basic and applied research
The number of projects in which any impact (on policy and
on practice) was identified was described just as ‘<10’, and so
not included in the statistical analysis
Shani et al., 2000 [85], Israel Israeli Ministry of Health’s
Medical Technologies
Administration/Israeli Center
for Technology in Health Care:
HTA
The number of projects in which any impact (only on policy)
was identified was described just as ‘86–100’, and so not
included in the statistical analysis; also the paper was a
commentary rather than a research report
Stryer et al., 2000 [86], United
States of America
Agency for Health Care and
Research Quality: Outcomes
and effectiveness research
The number of projects in which any impact (on policy and
on practice) was identified was described as ‘limited’, and so
could not be included in the statistical analysis
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technology appraisal reports that are the main element
of many HTA programmes [55]. The lower proportion
of projects in these studies (29%) demonstrating a policy
impact illustrates that variations in levels of impact
achieved can be linked to the type of research con-
ducted, even in the same overall field, which in this case
was further exacerbated by the impact assessment occur-
ring soon after the end of the trials [55].
Overall, as Jacob and McGregor reported for the
HTAs conducted in Canada by the Quebec CETS, “The
best insurance for impact is a request by a decider that
an evaluation be made” ([48], p. 78). Furthermore, for
those programmes (or parts of wider programmes) for
which there were explicit mechanisms such as formal
committees to receive and use the findings from tech-
nology appraisal reports in coverage decisions about in-
vestment or disinvestment, the proportion of projects
making an impact was very high.
Further examples of studies of the impact of multi-
project programmes have been published since the second
review was conducted, with the examples from Bangladesh,
Brazil, Ghana and Iran [2–5] illustrating a widening interest
in producing evidence of impact. In the Ghanaian example,
20 out of 30 studies were used to contribute to action, and
Kok et al. again showed that considerable levels of impact
could be achieved by adopting an interactive approach; they
reported that “the results of 17 out of 18 user-initiated stud-
ies were translated into action” ([4], p. 1). These four impact
assessments provide further evidence that contributes to
the global pool of studies showing the breadth of impact
made by health research, and also reinforces the evidence
that research impact assessment has become a rapidly
growing field.
As was noted, some individual studies provided lessons
for the specific funder on whose research they focussed as
to how that funder might best use its research resources.
Some more general lessons could also be drawn in terms
of the types of research programmes, for example, needs
led and collaborative ones, that seem to be more likely to
lead to impacts, though it is widely understood that
overall it is desirable for there to be a diversity of health
research funded. Additionally, the growing body of evi-
dence about the impacts that come from health research
could potentially be used to promote research funding
along the lines argued in the World Health Report 2013
[1]. Studies showing the monetary value in terms of a high
rate of return on health research expenditure, whether
from specific programmes or more widely, seem to have
particular potential to be used to promote the case for fur-
ther funding for medical research [77].
Lessons can also be learnt from the review about the
range of methods and frameworks available to conduct
health research impact assessments. Furthermore, in
addition to continuing refinement of existing frameworks,
for example, of the Canadian Academy of Health Sciences’
framework in Canada [87], there are also ever-increasing
numbers of studies on which to draw to inform analysis, in-
cluding current work in Australia [88]. Given the expanding
focus on research impact assessment, the potential lessons
that could be drawn from them, individually and collectively,
are likely to be more significant if there could be somewhat
greater standardisation. Any standardisation of methods
might attempt to reduce the current diversity on items such
as the categories of impact to include and their definition,
and the timing of data collection and its presentation. Such
moves towards standardisation might facilitate comparisons
between processes used in different programmes and, in that
way, inform strategic decisions that funding organisations
will always need to make as to how best to use resources.
Some ideas about standardisation, as well as some po-
tential dangers, might come from recent experience in
the United Kingdom where many research funders are
now using a standardised approach called Researchfish®
(Researchfish Ltd, Cambridge, United Kingdom). This is
an on-line survey, originally developed with the United
Kingdom’s Medical Research Council, that an increasing
number of research funders are now sending annually to
the PIs of all the projects they support. It asks for infor-
mation on outputs, outcomes and impacts (see Raftery
et al. [9] for a more detailed account). It has several advan-
tages, including a high formal response rate, wide use that
could facilitate comparability between programmes and
funders (though it does not currently report data in a way
that would have facilitated its use in the comparisons
made in our analysis), and a database that builds up a
fuller picture over successive years, including a number of
years after a project’s competition, thus allowing the cap-
ture of certain data that a one-off bespoke survey might
miss. Its main limitations include being a burden on re-
searchers (although this has been reducing as successive
versions of the assessment survey have been made more
user-friendly), the potential danger of a poorer response
rate to key questions than can be obtained by bespoke
surveys, and reduced specificity for some aspects of health
research because it has been standardised to cover many
research fields. As with other survey approaches,
Researchfish provides less detailed information and under-
standing than can come from case studies, but allows
wider coverage for the same resources.
How best to address these issues when seeking more
standardised approaches could be of interest to the newly
established WHO Global Observatory for Health Research
and Development [89]. Furthermore, perhaps there would
be scope for bringing together the expanding body of
evidence providing examples of the impact from pro-
grammes of health research, with the increasing sophisti-
cation, and global spread, of the analysis of factors that
might be associated with research use [90, 91].
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Conclusion
The quite high proportion of projects that reported mak-
ing an impact from some multi-project programmes, in-
cluding needs-led and collaborative ones, as well as the
demonstration of the monetary value of a programme,
could potentially be used to promote future research
funding along the lines argued in the World Health
Report 2013 [1]. This review also indicates that the evi-
dence about health research impact is continuing to grow.
In addition to being of value to research managers in iden-
tifying factors that might lead to increased impact, this review
of impact studies also demonstrates the range of methods
and conceptual frameworks that can be used in conducting
such studies. However, weaknesses in some studies, and di-
versity between studies in terms of methods and timing used,
reduces the value of some individual studies and the ability
to make comparisons within the full suite of 36 studies.
A standardised approach to assessing the impact of re-
search programmes could address existing methodological
inconsistencies and better inform strategic decisions about
research investment in order to enhance impact. However,
experience from the United Kingdom shows that moving
towards such standardisation can itself generate further
difficulties. There could be a role for the newly established
WHO Global Observatory for Health Research and Devel-
opment [89] in both drawing on the existing evidence
from many countries about the impact of health research
and in promoting ideas for achieving greater standardisa-
tion in health research impact assessment.
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